Glucosamine suppresses the nuclear factor-κB signaling via the O -linked- N -acetylglucosamine modification of inhibitor of κB kinase β in human synovial MH7A cells
Bioscience, Biotechnology, and Biochemistry · 2026
DOI: 10.1093/bbb/zbaf191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2026. Verfasst von Akimasa Someya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Systems Biomedicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Glucosamine, Signal Transduction, Acetylglucosamine, I-kappa B Kinase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: KAKENHI.
Abstract (Originalsprache)
We previously demonstrated that glucosamine (GlcN) exerts anti-inflammatory effects through the inhibition of nuclear factor-κB (NF-κB) signaling, possibly via O-linked-N-acetylglucosamine (O-GlcNAc) modification. In this study, we examined the effects of GlcN and alloxan (an inhibitor of O-linked-N-acetylglucosamine transferase) on NF-κB signaling molecules in interleukin (IL)-1β-stimulated human synovial MH7A cells. GlcN-induced O-GlcNAc modification of NF-κB and markedly inhibited IL-1β-induced nuclear translocation of the NF-κB, and phosphorylation of p65 subunit. GlcN also suppressed IL-1β-induced phosphorylation and degradation of inhibitor of κB (IκB). Moreover, GlcN promoted O-GlcNAc modification of IκB kinase (IKK) β, which phosphorylates IκBα, and concurrently inhibited its phosphorylation (activation). Notably, the effects of GlcN on NF-κB, IκBα, and IKKβ were reversed by alloxan. Finally, the inhibitory effect of GlcN on IL-8 production was eliminated in IKKβ-knockdown cells. Collectively, these findings indicate that O-GlcNAc modification of IKKβ is a key mediator of GlcN-induced suppression of NF-κB signaling and inflammatory cytokine production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Systems Biomedicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
ORCID-Profile: Akimasa Someya
Förderung
- KAKENHI
Zitieren
APA
Someya, A., & Nagaoka, I. (2026). Glucosamine suppresses the nuclear factor-κB signaling via the O -linked- N -acetylglucosamine modification of inhibitor of κB kinase β in human synovial MH7A cells. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbaf191
Vancouver
Someya A, Nagaoka I. Glucosamine suppresses the nuclear factor-κB signaling via the O -linked- N -acetylglucosamine modification of inhibitor of κB kinase β in human synovial MH7A cells. Bioscience, Biotechnology, and Biochemistry. 2026. doi:10.1093/bbb/zbaf191
BibTeX
@article{Someya2026,
author = {Someya, Akimasa and Nagaoka, Isao},
title = {Glucosamine suppresses the nuclear factor-κB signaling via the O -linked- N -acetylglucosamine modification of inhibitor of κB kinase β in human synovial MH7A cells},
journal = {Bioscience, Biotechnology, and Biochemistry},
year = {2026},
doi = {10.1093/bbb/zbaf191}
}
EUVIMED